Ramipril Capsule
Product Images NDC 65862-477

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 65862-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure of Ramipril, a drug for further processing. The diagram shows the molecular arrangement including chiral centers, amide bonds, carboxylic acid groups, and a fused bicyclic ring system typical of the Ramipril molecule.*

FDA Label Image

Figure 1. Kaplan-meier Estimates Of The Composite Outcome Of Myocardial Infarction, Stroke, Or Death From Cardiovascular Causes In The Ramipril Group And The Placebo Group (Ramipril Fig1)

A line graph comparing the proportion of patients over days of follow-up between Ramipril and Placebo groups. The x-axis represents days of follow-up up to about 1600 days, and the y-axis shows the proportion of patients up to 0.20. The graph features two lines: a solid line for Ramipril and a dashed line for Placebo, with a reported p-value of 0.0001 indicating statistical comparison.*

FDA Label Image

Figure 2. The Beneficial Effect Of Treatment With Ramipril On The Composite Outcome Of Myocardial Infarction, Stroke, Or Death From Cardiovascular Causes Overall And In Various Subgroups (Ramipril Fig2)

A forest plot chart illustrating the relative risk of composite outcomes in the Ramipril group versus placebo across various patient subgroups. It displays patient numbers, incidence percentages in the placebo group, and confidence intervals for relative risk associated with factors like cardiovascular disease, diabetes, age, sex, hypertension, and other medical histories.*

FDA Label Image

Package Label-principal Display Panel (1.25 mg (100 Capsule Bottle))

Label for Ramipril Capsules USP 1.25 mg by Aurobindo Pharma Limited. The label states the capsule strength as 1.25 mg and package count of 100 capsules. It includes the NDC number 65862-474-01, distributor information for Aurobindo Pharma USA, Inc., and warnings about storage and child safety.*

FDA Label Image

Package Label-principal Display Panel (1.25 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Ramipril Capsules, USP 1.25 mg from Aurobindo Pharma Limited. The label indicates a package of 100 capsules presented as 10 x 10 unit-dose capsules. It includes the NDC 65862-474-10 and notes that each hard gelatin capsule contains 1.25 mg of Ramipril. The label design features teal and purple accents with the brand name and strength prominently displayed.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg (100 Capsule Bottle))

Label for Ramipril Capsules, USP 2.5 mg, containing 100 capsules for further processing. Distributed by Aurobindo Pharma USA, Inc., made in India. The label includes administration notes, a warning to keep out of reach of children, pharmacist dispensing instructions, storage conditions, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg Blister Carton (10 x 10 Unit-dose))

Label for Ramipril Capsules, USP 2.5 mg by Aurobindo Pharma Limited. The label indicates the product is prescription-only and contains 100 capsules in a 10 x 10 unit-dose format. The label includes strength information and dosage form, along with the NDC 65862-475-10 and distributor details. The design features the Aurobindo logo and color accents in teal and purple.*

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Capsule Bottle))

Label for Ramipril Capsules USP 5 mg by Aurobindo Pharma Limited. The label states each hard gelatin capsule contains Ramipril USP 5 mg and includes storage instructions, pharmacist dispensing guidance, and distributor information listing Aurobindo Pharma USA, Inc. The label indicates the package contains 100 capsules and features the NDC 65862-476-01 and a barcode.*

FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Ramipril Capsules, USP 5 mg by Aurobindo Pharma Limited. The carton holds 100 capsules (10 x 10 unit-dose). The label includes dosage strength, quantity, and distributor information with a barcode and Rx only designation.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Capsule Bottle))

Label for Ramipril Capsules USP 10 mg by Aurobindo Pharma Limited. The label states the product contains 100 capsules, each hard gelatin capsule contains 10 mg of Ramipril. It includes storage instructions, a warning to keep out of reach of children, and pharmacist dispensing guidance. The label also shows distributor information for Aurobindo Pharma USA, Inc. and a barcode.*

FDA Label Image

Package Label-principal Display Panel (10 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Ramipril Capsules, USP 10 mg, distributed by Aurobindo Pharma USA, Inc. The label indicates the product contains 100 capsules (10 x 10 unit-dose). It includes prescription only (Rx only) designation, the NDC code 65862-477-10, and storage instructions. The label features the Aurobindo logo and states the drug is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.